At a time when low-cost generic drugs are being embraced as among the few ways to slow skyrocketing health care costs, the FDA has a backlog of more than 800 applications to bring new generic products to the market -- an all-time high.
As a result, experts say, fewer generic drugs will be available to consumers in the years ahead than the industry is ready and able to provide.
But wait. Here's the kicker.
The FDA, however, has told Congress that the office that reviews new generics needs no additional money, and the agency has no plans to hire more reviewers.
A situation Big Pharma will, no doubt, find most satisfactory!
Source: MSNBC
1 comment:
the FDA is a good little whore...
you should stop picking on them...they work hard for their blood money, you know.
Post a Comment